@ARTICLE{
author={Koehne Claus-Henning,Bedenne Laurent,Carrato Alfredo,Bouche Olivier,Popov Ivan P,Gaspa Losa,Valladares Manuel,Rougier Phillipe,Gog Christiane,Reichardt Peter,Wils Jacques,Pignatti Francesco,Biertz Frank},
year={2013},
title={A randomised phase III intergroup trial comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus 5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: The Pan-European Trial in Adjuvant Colon Cancer 2 study},
journal={EUROPEAN JOURNAL OF CANCER},
volume={49},
number={8},
pages={1868-1875},
document_type={Article},
} 

@ARTICLE{
author={Popov Ivan P,Carrato Alfredo,Sobrero Alberto,Vincent Mark,Kerr David,Labianca Roberto,Bianco Angelo Raffaele,El-Serafi Mostafa,Bedenne Laurent,Paillot Bernard,Mini Enrico,Sanches Evaristo,Welch John,Collette Laurence,Praet Michel,Wils Jacques},
year={2008},
title={Raltitrexed (Tomudex (R)) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)},
journal={EUROPEAN JOURNAL OF CANCER},
volume={44},
number={15},
pages={2204-2211},
document_type={Article},
}